FDA Recalls Finder

FDA Approves Therapy to Treat Gaucher Disease
26 February 2010, 6:26 pm

The U.S. Food and Drug Administration has approved velaglucerase alfa for injection (VPRIV) to treat children and adults with a form of the rare genetic disorder Gaucher disease.

Source: Food and Drug Administration--Press Releases